Riskpilot← Back to searchSign inGet full accessMeloni-Med Oy
OYActiveY-tunnus 1616323-4Tiilimäki 12-as2Medical specialists activities · NACE 8622Est. 2000— employees
Revenue 2024
EUR 293K
-14% vs 2023
EBITDA margin
52.6%
-4% vs 2023
Equity ratio
97.1%
Financial strength
Net profit 2024
EUR 125K
-5% vs 2023
| Revenue | EUR 293K | -14% |
| EBITDA | EUR 154K | -4% |
| Net profit | EUR 125K | -5% |
| Total assets | EUR 1M | +6% |
| Equity | EUR 998K | +5% |
| Employees | — | — |
Legal name
Meloni-Med Oy
Y-tunnus number
1616323-4
Legal form
Osakeyhtiö
NACE code
8622 · Medical specialists activities
Founded
1. heinäkuuta 2000
Share capital
EUR 2 500
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin
Company purpose
Yhtiön toimialana on lääkäri- ja terveydenhoitoalan palvelujen myynti, terveysalan tutkimukset, koulutus, alan kirjallisuuden tuottaminen ja julkaiseminen. Yhtiö voi ostaa ja myydä osakkeita, arvopapereita ja harjoittaa muuta sijoitustoimintaa sekä ostaa, vuokrata ja myydä huoneistoja ja kiinteistöjä.
Address
Tiilimäki 12-as2
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 369 | 353 | 317 | 340 | 293 |
| Staff expenses | −54 | −57 | −129 | −95 | −45 |
| EBITDA | 249 | 229 | 116 | 160 | 154 |
| Depreciation & amort. | −3 | −2 | −2 | −2 | −1 |
| EBIT | 246 | 227 | 114 | 158 | 153 |
| Net financials | −0 | 3 | −2 | 7 | 4 |
| Profit before tax | 246 | 230 | 112 | 165 | 157 |
| Tax | 49 | 46 | 23 | 33 | 32 |
| Net profit | 196 | 185 | 89 | 132 | 125 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 853 | 901 | 909 | 969 | 1 028 |
| Equity | 809 | 869 | 888 | 949 | 998 |
| Long-term debt | — | — | — | 0 | 0 |
| Short-term debt | 44 | 32 | 21 | 20 | 30 |
| Total debt | 44 | 32 | 21 | 20 | 30 |
EBITDA margin
52.6%
This company
15.8%
Market median
+233% vs market
20202024
Equity ratio
97.1%
This company
38.2%
Market median
+154% vs market
20202024
Return on equity
12.5%
This company
18.4%
Market median
+32% vs market
20202024
Net profit margin
42.7%
This company
8.1%
Market median
+427% vs market
20202024
Asset turnover
0.29×
This company
1.12×
Market median
-74% vs market
20202024
Debt / equity
0.03×
This company
0.62×
Market median
+95% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
KH Deputy Member | Deputy Member | 2020 |
TT | Audit | 2020 |
AO Deputy auditor | Deputy auditor | 2023 |
| Former (3) | ||
JA Deputy Member | Deputy Member | 2000 – 2020 |
SO Deputy auditor | Deputy auditor | 2006 – 2020 |
RT Deputy auditor | Deputy auditor | 2020 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2000 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Meloni-Med Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jarkko Aslak Antikainen | Deputy Member | 0 companies |
| Kaisa Helinä Antikainen | Deputy Member | 0 companies |
| Tarja Tuulikki Tolvanen | Audit | 0 companies |
| Seppo Olavi Laukkanen | Deputy auditor | 0 companies |
| Riitta Tellervo Kallio-Saukkonen | Deputy auditor | 0 companies |
| Asla Olavi Lindgrén | Deputy auditor | 0 companies |
| Lauri Erik Antikainen | Board of Directors | 0 companies |